KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Receivables Refunds: 2019-2021

Historic Receivables Refunds for Travere Therapeutics (TVTX) over the last 2 years, with Dec 2021 value amounting to $247,000.

  • Travere Therapeutics' Receivables Refunds fell 98.56% to $247,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $247,000, marking a year-over-year decrease of 98.56%. This contributed to the annual value of $247,000 for FY2021, which is 98.56% down from last year.
  • Travere Therapeutics' Receivables Refunds amounted to $247,000 in Q4 2021, which was down 39.01% from $405,000 recorded in Q3 2021.
  • Travere Therapeutics' Receivables Refunds' 5-year high stood at $20.2 million during Q1 2020, with a 5-year trough of $247,000 in Q4 2021.
  • In the last 3 years, Travere Therapeutics' Receivables Refunds had a median value of $13.6 million in 2020 and averaged $10.1 million.
  • As far as peak fluctuations go, Travere Therapeutics' Receivables Refunds soared by 1,128.82% in 2020, and later tumbled by 98.56% in 2021.
  • Over the past 3 years, Travere Therapeutics' Receivables Refunds (Quarterly) stood at $1.4 million in 2019, then skyrocketed by 1,128.82% to $17.1 million in 2020, then crashed by 98.56% to $247,000 in 2021.
  • Its last three reported values are $247,000 in Q4 2021, $405,000 for Q3 2021, and $400,000 during Q2 2021.